Atopic Dermatitis

Abrocitinib downregulated genes associated with inflammation, epidermal hyperplasia, and T helper 2 and T helper 22 responses in the skin of patients with moderate to severe atopic dermatitis, according to a study published in Allergy.

Climatic hazards associated with greenhouse gas emissions may exacerbate atopic dermatitis, including severity and flares, while increasing its prevalence and related health care utilization, according to a review published in Allergy.

An association between moderate to severe atopic dermatitis and inflammatory bowel disease suggests a multidisciplinary approach to AD may be necessary, according to a study.

Patients with atopic dermatitis experienced greater risks for asthma, asthma exacerbations and hospitalizations than those without AD, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Dupixent for atopic dermatitis has received a label update from the FDA adding phase 3 efficacy and safety data, Regeneron and Sanofi announced in a press release.

According to analyses of new phase 3 data, patients with atopic dermatitis that were treated with Vtama cream 1% maintained long-term improvement even after stopping treatment, Dermavant announced in a press release.

Patients with atopic dermatitis and plaque psoriasis who were treated with a topical phosphodiesterase 4 inhibitor exhibited significant improvement, according to a study.

Careers in allergy and asthma can take physicians into private, corporate or academic work as well as into professional organizations. Michael S. Blaiss, MD, a new member of Healio’s Allergy/Asthma Peer Perspective Board, has done it all.

The FDA has granted priority review to omalizumab as a treatment for food allergy after accidental exposure, according to a press release.

Healio’s top atopic dermatitis stories described evidence supporting various treatments, including two reviews of dozens of approaches, as well as physical and mental comorbidities, among other topics.